wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35252544-82C52385-1149-4D11-8002-D26B447AED28
Q35252544-82C52385-1149-4D11-8002-D26B447AED28
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35252544-82C52385-1149-4D11-8002-D26B447AED28
Estimating treatment effects for individual patients based on the results of randomised clinical trials.
P2860
Q35252544-82C52385-1149-4D11-8002-D26B447AED28
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35252544-82C52385-1149-4D11-8002-D26B447AED28
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9033bd29759be17c4ab2c99e9874d8f1c075d553
P2860
Rosuvastatin for primary prevention among individuals with elevated high-sensitivity c-reactive protein and 5% to 10% and 10% to 20% 10-year risk. Implications of the Justification for Use of Statins in Prevention: an Intervention Trial Evaluating R